Paul Curley
University of Liverpool(GB)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, HIV/AIDS drug development and treatment, COVID-19 Clinical Research Studies, Advanced Drug Delivery Systems, SARS-CoV-2 detection and testing
Most-Cited Works
- → FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2(2022)288 cited
- → Prioritization of Anti‐SARS‐Cov‐2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics(2020)167 cited
- → Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis: Relationship to endotoxin, interleukin 6 and disease severity(1993)99 cited
- → Antiretroviral Solid Drug Nanoparticles with Enhanced Oral Bioavailability: Production, Characterization, and In Vitro–In Vivo Correlation(2013)89 cited
- → Common peroneal nerve dysfunction after high tibial osteotomy(1990)61 cited
- → Inhibitory Effects of Commonly Used Excipients on P-Glycoprotein in Vitro(2018)58 cited
- → Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis(2020)56 cited
- → The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery(2017)51 cited
- → Predicting Drug–Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling(2018)47 cited
- → Decreased interleukin-2 production in murine acute pancreatitis: Potential for immunomodulation(1996)47 cited